Home » Topics » Regulatory » Patents

Patents
RSS

KCNC1/KCNC2 channel modulators presented by Autifony Therapeutics

July 10, 2018

Amgen discovers new beta-secretase inhibitors

July 10, 2018

New mutant EGFR inhibitors identified at Medshine Discovery

July 9, 2018

Laboratorios del Dr. Esteve discovers dual mu-opioid/sigma1R ligands

July 9, 2018

Hangzhou Innogate Pharma divulges protein kinase inhibitors

July 9, 2018

Leo Pharma presents phosphodiesterase PDE4 inhibitors

July 9, 2018

Fatty acid synthase inhibitors synthesized at Cephalon

July 9, 2018

mAChR antagonists/beta2-adrenoceptor agonists patented by Beijing Showby Pharmaceutical

July 9, 2018

Medshine Discovery and collaborator patent CCR-2 and CCR-5 antagonists

July 6, 2018

Nanjing TransThera Biosciences synthesizes protein kinase inhibitors for cancer

July 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...